Ocugen announces new updates to its Retina SAB, Executive Leadership Team

Ocugen (OCGN) announced updates to its Retina Scientific Advisory Board, SAB, and Executive Leadership Team to enhance external guidance from key opinion leaders and strengthen the Company’s internal expertise in critical functions and as it pursues its goal of three BLAs in the next three years. New SAB members include: Jeffrey Heier, MD; Peter Kaiser, MD; Arshad Khanani, MD. Vijay Tammara, PhD, has joined Ocugen in the newly created position of Chief Development Officer. Abhi Gupta, MBA, has been named Executive Vice President, Commercial and Business Development, following the retirement of Mike Shine.